Ke-jie Wang
#59 Liuting Street
Ningbo, 315010, China
Ningbo, 315010, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Current status of radionuclide therapies in metastatic castration-resistant prostate cancer.
Journal: Therapeutic advances in medical oncology
Published: June 01, 2025
Sinularin induces autophagy-dependent cell death by activating ULK1 and enhancing FOXO3-ATG4A axis in prostate cancer cells.
Journal: Scientific reports
Published: February 04, 2025
Research progress on circular RNA in the regulation of drug resistance in genitourinary cancers.
Journal: Cellular and molecular life sciences : CMLS
Published: November 19, 2024
Promising therapy for neuroendocrine prostate cancer: current status and future directions.
Journal: Therapeutic advances in medical oncology
Published: April 09, 2024
RON receptor tyrosine kinase as a critical determinant in promoting tumorigenic behaviors of bladder cancer cells through regulating MMP12 and HIF-2α pathways.
Journal: Cell death & disease
Published: April 08, 2024
Sinularin stabilizes FOXO3 protein to trigger prostate cancer cell intrinsic apoptosis.
Journal: Biochemical pharmacology
Published: September 03, 2023
The down-regulation of GADD45B leads to a conversion of cellular oxidative phosphorylation to glycolysis and promotes the progression of bladder cancer.
Journal: Heliyon
Published: May 15, 2023
Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression.
Journal: Aging
Published: March 22, 2022
The expression and significance of p4E-BP1/4E-BP1 in prostate cancer.
Journal: Journal of clinical laboratory analysis
Published: January 19, 2022
Emodin Induced Necroptosis and Inhibited Glycolysis in the Renal Cancer Cells by Enhancing ROS.
Journal: Oxidative medicine and cellular longevity
Published: September 02, 2020
Last Updated: 09/26/2026